| Financial Year |
March 31 2023 |
| Monetary Funds |
643,108,680.96 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,150,000.00 |
| Accounts Receivable |
211,992,974.21 |
| Advances to Suppliers |
67,316,319.84 |
| Other Receivables |
371,274,648.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
636,677,751.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,583,081.08 |
| Total Current Assets |
1,975,842,127.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
47,285,000.00 |
| Long-term Equity Investment |
1,046,380,442.38 |
| Investment Properties |
833,843,512.79 |
| Fixed Assetes |
27,490,535.13 |
| Under-construction Projects |
1,556,732.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,963,351.31 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,405,861.54 |
| Deferred Income Tax Assets |
69,722,010.09 |
| Other Non-Current Assets |
15,423,978.43 |
| Sub-Total of Non-Current Assets |
2,140,602,229.61 |
| Total Assets |
4,116,444,357.20 |
| Short-Term Loans |
1,137,699,659.39 |
| Trading Financial liabilities |
-- |
| Notes Payable |
203,492,818.51 |
| Accounts Payable |
169,641,009.67 |
| Accounts Received In Advance |
28,853,591.74 |
| Employee Compensation Payable |
4,781,507.96 |
| Taxes Payable |
59,282,072.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
132,394,419.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
473,920,434.38 |
| Other Current Liabilities |
20,286,989.14 |
| Sub-Total of Current Liabilities |
2,443,021,159.77 |
| Long-term Loans |
108,885,622.40 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
36,974.40 |
| Special Payable |
-- |
| Estimatied Liabilities |
692,992.48 |
| Deferred Income Tax Liabilities |
8,205,503.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
141,731,341.66 |
| Total Liabilities |
2,584,752,501.43 |
| Paid-In Capital(Or Share Stock) |
453,828,600.00 |
| Capital Surplus |
1,204,139,255.06 |
| Surplus Reserve |
23,182,179.63 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
21,021,720.79 |
| Minority Stockholder's Interest |
65,026,785.64 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,466,665,070.13 |
| Owner's Equity（Stockholder's Equity） |
1,531,691,855.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,116,444,357.20 |
